Skip to content
Back to the Guavy Wire
Stocks

Analysts Divided on Healthcare Stocks Insulet UnitedHealth and Ottobock

Instruments
UNH
Share

Analysts have recently shared their views on three healthcare stocks: Insulet (PODD), UnitedHealth (UNH), and Ottobock SE & Co. KGaA (OBCKF). Robert W. Baird analyst Jeff Johnson downgraded Insulet to Hold with a price target of $158.00, while the stock closed last Thursday at $137.23. Johnson, a 5-star analyst, has an average return of 9.7% and a 49.6% success rate. Despite the downgrade, Insulet maintains a Moderate Buy consensus among analysts, with a price target consensus of $172.85, suggesting a 23.8% upside.

UnitedHealth received a Buy rating and a $455.00 price target from TD Cowen analyst Ryan Langston. The stock closed last Thursday at $330.48. Langston, a 3-star analyst, covers the healthcare sector. The broader analyst consensus for UnitedHealth is a Strong Buy, with an average price target of $486.00, indicating a 38.4% potential upside.

Ottobock SE & Co. KGaA was maintained as a Buy by Jefferies analyst Henrik Paganetty, who set a price target of EUR83.00. Despite this, the stock has a Strong Buy consensus with an average price target of $73.69, which represents a -99.1% downside from current levels. Deutsche Bank also maintained a Buy rating with a EUR56.00 price target.

More on Stocks